Medy-Tox Inc. (KOSDAQ:086900)
South Korea flag South Korea · Delayed Price · Currency is KRW
128,800
-300 (-0.23%)
At close: Feb 27, 2026

Medy-Tox Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
22,81716,9559,75537,01094,154-29,577
Depreciation & Amortization
19,95919,95915,37615,10118,25618,597
Loss (Gain) From Sale of Assets
-323.58-323.58671.97230.42-131.48-58.63
Asset Writedown & Restructuring Costs
8,6248,624--12,9324,382
Loss (Gain) From Sale of Investments
-125.73-125.73593.363,044-2,6661,067
Loss (Gain) on Equity Investments
-5,877-5,877-1,363-5,1291,4562,432
Stock-Based Compensation
-552.97-552.971,8321,8073,9024,116
Provision & Write-off of Bad Debts
4,8854,885546.644,8691,16214,418
Other Operating Activities
-4,8131,2582,174-1,232-79,4698,668
Change in Accounts Receivable
4,3194,319-35,633-22,9694,440-1,986
Change in Inventory
-3,449-3,449-8,905-19,4621,405-12,269
Change in Accounts Payable
-3,373-3,37319,508840.32807.578,166
Change in Unearned Revenue
177.95177.95----
Change in Other Net Operating Assets
19,028-5,9218,96612,089-36,2829,971
Operating Cash Flow
61,29636,55613,52226,19919,96627,927
Operating Cash Flow Growth
205.83%170.35%-48.39%31.22%-28.51%-17.14%
Capital Expenditures
-7,628-8,726-7,660-9,895-17,514-41,144
Sale of Property, Plant & Equipment
67.94267.5125.7323.051,171366.27
Cash Acquisitions
-5,147-4,920--911.23--
Sale (Purchase) of Intangibles
-17,836-9,714-29,809-15,205-3,830-3,162
Investment in Securities
44,50821,11147,388-10,066-11,803-8,806
Other Investing Activities
1,3921,0742,338465.624,004873.46
Investing Cash Flow
15,289-646.9213,255-36,124-27,777-52,024
Short-Term Debt Issued
-20,00041,23037,30319,75083,394
Long-Term Debt Issued
-----67,000
Total Debt Issued
-20,00041,23037,30319,750150,394
Short-Term Debt Repaid
--20,561-43,905-38,000-38,590-102,268
Long-Term Debt Repaid
--759.23-5,624-12,634-918.71-670.55
Total Debt Repaid
-6,043-21,321-49,529-50,634-39,508-102,939
Net Debt Issued (Repaid)
-6,043-1,321-8,299-13,331-19,75847,456
Issuance of Common Stock
43.15141.29,943--197.24
Repurchase of Common Stock
-20,295-10,148-2,972-16,935-8,125-10,405
Dividends Paid
-8,424-8,424-8,422-8,045--5,539
Other Financing Activities
-11,193-4,296-3,794-2,077-2,313-2,991
Financing Cash Flow
-45,912-24,048-13,544-40,38834,80450,718
Foreign Exchange Rate Adjustments
755.871,061-674.63-777.04791.78-2,645
Miscellaneous Cash Flow Adjustments
0-----
Net Cash Flow
31,42912,92212,558-51,08927,78423,977
Free Cash Flow
53,66827,8305,86216,3042,452-13,217
Free Cash Flow Growth
361.03%374.76%-64.05%564.95%--
Free Cash Flow Margin
22.20%12.17%2.65%8.36%1.33%-9.38%
Free Cash Flow Per Share
8351.164138.95875.312483.66382.01-2059.99
Cash Interest Paid
2,5694,3303,8042,4133,6322,576
Cash Income Tax Paid
8,3727,45613,48618,87617,991-5,234
Levered Free Cash Flow
29,92825,136-25,434-7,85014,556-35,491
Unlevered Free Cash Flow
31,00726,215-23,976-6,40417,544-32,881
Change in Working Capital
16,704-8,245-16,064-29,501-29,6303,881
Source: S&P Global Market Intelligence. Standard template. Financial Sources.